HealthEquity (NASDAQ:HQY) Sets New 1-Year Low on Analyst Downgrade

Shares of HealthEquity, Inc. (NASDAQ:HQY) reached a new 52-week low during trading on Wednesday after BTIG Research lowered their price target on the stock from $130.00 to $110.00. BTIG Research currently has a buy rating on the stock. HealthEquity traded as low as $72.76 and last traded at $74.36, with a volume of 987588 shares. The stock had previously closed at $73.88.

Several other research firms have also issued reports on HQY. Barclays started coverage on shares of HealthEquity in a research report on Monday, December 8th. They set an “overweight” rating and a $118.00 price target for the company. Citizens Jmp set a $122.00 price target on HealthEquity in a research report on Thursday, December 4th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research report on Thursday, January 22nd. JPMorgan Chase & Co. lifted their target price on shares of HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. Finally, Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Monday, January 19th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $116.13.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. The trade was a 1.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the transaction, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 13,959 shares of company stock valued at $1,344,957 in the last ninety days. 1.50% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. William Blair Investment Management LLC purchased a new position in shares of HealthEquity in the 4th quarter valued at approximately $169,956,000. Norges Bank bought a new position in HealthEquity in the fourth quarter worth $66,927,000. Westfield Capital Management Co. LP lifted its position in HealthEquity by 124.6% during the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after buying an additional 701,819 shares during the period. AQR Capital Management LLC boosted its holdings in shares of HealthEquity by 148.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after buying an additional 661,795 shares in the last quarter. Finally, Cadian Capital Management LP purchased a new stake in shares of HealthEquity in the 4th quarter worth about $51,915,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

The company has a market capitalization of $6.35 billion, a P/E ratio of 34.11, a price-to-earnings-growth ratio of 0.92 and a beta of 0.24. The company’s 50 day moving average is $87.65 and its 200-day moving average is $91.95. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The business had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. During the same quarter in the prior year, the company earned $0.78 earnings per share. The business’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.